ReviewMicrobial genomics2020
Using genomics to understand meticillin- and vancomycin-resistant
Review in Microbial genomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 38 citations in OpenAlex.
- Fast hospital discharge rates blur within-hospital 'transmission footprint' in bacterial genomes, as showcased with Staphylococcus aureus.PLoS computational biology · 2026Article
- Pristinamycin-antibiotic combinations against methicillin-resistant Staphylococcus aureus recovered from skin infections.BMC infectious diseases · 2025Article
- Photoactive Hydrogels as Materials for Biological Applications: Preparation of Thermally Stable Photoactive Films.Gels (Basel, Switzerland) · 2025Article
- A multi-hospital, clinician-initiated bacterial genomics programme to investigate treatment failure in severe Staphylococcus aureus infections.Nature communications · 2025Article
- Article
- GEO dataset mining analysis reveals novelFrontiers in molecular biosciences · 2024Article
- Genomic characterization and outbreak investigations of methicillin-resistantFrontiers in microbiology · 2024Article
- Virulence attributes of successful methicillin-resistantClinical microbiology reviews · 2023Review
- Case Commentary: The hidden side of oxacillin resistance inAntimicrobial agents and chemotherapy · 2023Article
- The Plasmidomic Landscape of Clinical Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2023Article
- Dissemination Pattern of Hospital-Acquired Methicillin-ResistantThe Malaysian journal of medical sciences : MJMS · 2023Review
- Methicillin-resistantEmerging microbes & infections · 2022Article
- Genetic Diversity among Methicillin-ResistantTropical medicine and infectious disease · 2022Review
- Phylodynamic signatures in the emergence of community-associated MRSA.Proceedings of the National Academy of Sciences of the United States of America · 2022Article
- Improved diagnostic prediction of the pathogenicity of bloodstream isolates of Staphylococcus epidermidis.PloS one · 2021Article
- Enhanced eradication of intracellular and biofilm-residing methicillin-resistant Staphylococcus aureus (MRSA) reservoirs with hybrid nanoparticles delivering rifampicin.International journal of pharmaceutics · 2020Article
- Setting the standard: multidisciplinary hallmarks for structural, equitable and tracked antibiotic policy.BMJ global health · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Resistance to meticillin and vancomycin in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.